Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliflapon in African American Patients With Coronary Artery Disease
NCT00353067Phase 3Suspended
- Sponsor
- deCODE genetics
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of veliflapon in coronary artery disease (CAD), sponsored by deCODE genetics. Started May 2006; status: suspended.
02
Drugs
veliflapon
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00353067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353067.